PF-AtlasКлинические испытания › NCT03919604

ECMO for Lung Transplantation in Cystic Fibrosis Patients

Extracorporeal Life Support · Не указано

ID реестра
NCT03919604
Фаза
Не указано
Статус
Завершено
Препарат / вмешательство
Extracorporeal Life Support
Спонсор
Policlinico Hospital
Начало
2013-01-01
Набор участников
80
Центры
1

Об исследовании

Cystic fibrosis (CF) is the most common genetically inherited disease in the Caucasian population. Bilateral lung transplantation (LUTX) is a viable option for these patients. Frequently, the surgical operation of LUTX is complicated by hemodynamic instability, intractable hypoxia and respiratory acidosis. For these reasons, Intraoperative extracorporeal life support - ECLS- is required. Data on predictors of use of intraoperative ECLS in CF patients undergoing LUTX is scarce. Aim of this retrospective observational study was 1) to find possible risk factors at the time of enlistment associated with the intraoperative use of ECLS and 2) to compare the outcomes of CF patients treated with ECLS during LUTX or not.

Открыть NCT03919604 на ClinicalTrials.gov →

Связанные материалы

Медицинская оговорка. Эта страница обобщает публичные данные исследования NCT03919604 только для информации. Это не медицинская рекомендация, не одобрение и не предложение участия. Проверяйте детали на ClinicalTrials.gov и у квалифицированного врача.